FGF-18 compound dosing regimen

• 收藏
• 分享

专利权人:

Merck Patent GmbH

发明人:

Ladel, Christoph H.,Guehring, Hans

申请号：

AU2015220773

公开号：

AU2015220773A1

申请日:

2015.02.20

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention provides a new dosing regimen for administration of FGF18 in the treatment of a cartilage disorder, such as osteoarthritis or cartilage injury. Specifically provided is a preferred treatment scheme comprising administrations every 3 weeks, 4 weeks or 5 weeks of an FGF-18 compound per treatment cycle. The new dosing regimen can include the co-adminsitration of a anti-inflammatory drug.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/